Amprius Technologies, Inc.

Listed Company

AMPXCIK 0001899287NYSEEmerging GrowthMiscellaneous Electrical Machinery, Equipment & SuppliesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$73.01M

Net Income

$-44.00M

Total Assets

$156.89M

Equity

$103.81M

Shares Out

137.02M

Op. Cash Flow

$-31.13M

Business

Amprius Technologies, Inc. designs, develops, manufactures and markets high-performance lithium‑ion batteries for mobility applications, primarily serving aviation as well as electric vehicle (EV) and light electric vehicle (LEV) markets. Its main products are silicon‑anode battery platforms, offered under the SiCore and SiMaxx product families, which provide high energy density, high power and fast‑charge capabilities. The company operates product and manufacturing activities across silicon anode development, cell design and contract manufacturing partnerships. It sells batteries and design services to aerospace firms, defense customers and transportation OEMs through direct customer engagements and global contract manufacturers, with supply arrangements covering North America.

Summary from filing dated 2025-03-20

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	73	24	9	4	3
Cost of revenue	65	42	24	10	7
Gross profit (loss)	8	−18	−15	−6	−4
Research and development	9	7	4	2	1
Selling, general and administrative	23	19	20	10	5
Impairment and other	23	2	—	—	—
Total operating expenses	55	28	24	12	6
Loss from operations	−47	−46	−39	−18	−11
Interest income and other, net	3	2	3	709,000	−16,000
Total other income, net	3	2	2	709,000	727,000
Net loss	−44	−45	−37	−17	−10
Weighted-average common shares outstanding, basic (in shares)	125	102	86	71	66
Weighted-average common shares outstanding, diluted (in shares)	125	102	86	71	66
Net loss per share of common stock, basic (in dollars per share)	−0.35	−0.45	−0.43	−0.24	−0.15
Net loss per share of common stock, diluted (in dollars per share)	−0.35	−0.45	−0.43	−0.24	−0.15

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	91	55	46	70	11
Accounts receivable, net	24	6	1	700,000	700,000
Inventories	7	7	730,000	500,000	500,000
Prepaid expenses and other current assets	6	1	2	2	156,000
Total current assets	126	69	51	75	14
Property, plant and equipment, net	10	17	22	4	4
Operating lease right-of-use assets, net	20	34	35	3	3
Other assets	1	1	305,000	644,000	0
Total assets	157	121	108	83	19
Accounts payable	7	7	3	1	359,000
Accrued and other current liabilities	4	5	6	3	1
Deferred revenue	100,000	2	3	3	2
Deferred grant	3	0	—	—	—
Operating lease liabilities	5	3	1	521,000	0
Total current liabilities	18	17	13	7	4
Operating lease liabilities	35	34	34	3	0
Total liabilities	53	52	48	10	5
Commitments and contingencies (Note 10)	—	—	—	—	—
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0	0	0	0
Common stock; $0.0001 par value; 950,000,000 shares authorized; 134,536,592 and 116,934,314 shares issued and outstanding at December 31, 2025 and 2024, respectively	13,000	12,000	9,000	8,000	7,000
Additional paid-in capital	322	244	189	166	89
Accumulated other comprehensive income	4,000	0	—	—	—
Accumulated deficit	−218	−174	−130	−93	−75
Total stockholders equity	104	69	60	73	14
Total liabilities and stockholders equity	157	121	108	83	19

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Stock-based compensation	7	7	4	3	2
Depreciation and amortization	4	4	2	2	1
Amortization of deferred costs	0	1	3	2	548,000
Non-cash operating lease expense	5	5	1	556,000	0
Other non-cash items	454,000	0	—	—	—
Accounts receivable, net	−19	−4	−579,000	−424,000	86,000
Inventories	−161,000	−6	−230,000	0	17,000
Deferred costs	0	−467,000	−2	−2	−2
Prepaid expenses and other current assets	−4	533,000	407,000	−2	−70,000
Other assets	28,000	−17,000	−9,000	0	—
Accounts payable	−998,000	6	616,000	517,000	−2
Accrued and other current liabilities	−1	−747,000	3	1	574,000
Deferred revenue	−2	−2	54,000	—	—
Deferred grant	3	0	—	—	—
Operating lease liabilities	−3	−1	−1	−482,000	0
Net cash used in operating activities	−31	−33	−26	−14	−8
Purchase of property, plant and equipment	−4	−3	−18	−1	−609,000
Net cash used in investing activities	−4	−3	−18	−1	−609,000
Proceeds from issuance of common stock upon exercise of stock warrants	2	14	1,000	2	0
Payment of equity financing costs	0	−756,000	−601,000	−326,000	0
Proceeds from exercise of stock options	5	109,000	310,000	44,000	1,000
Net cash provided by financing activities	71	47	19	74	20
Net increase in cash, cash equivalents and restricted cash equivalents	36	11	—	—	—
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents	4,000	0	—	—	—
Unpaid purchases of property, plant and equipment	322,000	48,000	2	83,000	51,000
Increase in fair value of modified stock warrants	0	727,000	0	—	—
Cancellation and retirement of common stock	0	1,000	—	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro